In a recent Penny Stock Detectives article, editor Danny Esposito argues that in spite of the controversy surrounding stem cell research worldwide, biotech companies are encouraging research in the area because of its potential to revolutionize treatments for currently incurable disorders. Esposito notes that, even in small case studies, the treatment of patients once thought untreatable with ...
